Exposure To Solvents A Health Risk PDF Print E-mail
Tuesday, 28 June 2011 01:11
taken from http://www.flickr.com/photos/ricephotos/438518404/sizes/z/in/photostream/ via creative commonsExposure to solvents by medical laboratory workers may be a health risk according to a new study from the University of Otago, Wellington just published in The Journal of Rheumatology. "Our study of 341 medical laboratory workers indicates they are more likely to develop a condition called Raynaud's phenomenon, if they are exposed to solvents such as toluene or xylene. This raises concerns they could then have further serious health complications later in life," says lead researcher Gordon Purdie.

This is the first ever research to show an occupational health hazard involving solvent use and Raynaud's phenomenon (RP). Other studies overseas have shown similar solvent associations, but not with people exposed to solvents at work.

Raynaud's phenomenon is vasoconstriction, or the narrowing of blood vessels in the hands and other extremities, and is characterized by pain, colour changes and tautness or fullness of the fingers or toes. Raynaud's phenomenon usually only occurs in cold conditions. For some people it may be a symptom or precursor of scleroderma, a rare connective tissue disease affecting multiple systems in the body and mainly amongst women.

The mainly female laboratory workers (79%) who used solvents in this study had higher rates of severe RP. Those who had worked with xylene or toluene doubled their risk of developing severe RP. It appears that lab workers who worked with acetone or chlorinated solvents, combined with xylene or toluene, also doubled their risk of developing RP. Risk of developing severe RP was even greater, in fact nine times.

"I am concerned that 75% of those who worked with xylene or toluene handled wet sample slides without gloves. The majority had done so daily for over a decade," says Purdie. "Absorption through the skin is a classic way for solvents to have a negative impact on health."

Purdie says the study also found no difference in severe RP rates between the general population and those lab workers who had not used solvents in their work.

He says this study highlights the need to minimise exposure and be careful in handling solvents in medical laboratories and other workplaces. Co-author and Senior Lecturer in Rheumatology at the University of Otago, Wellington, Dr Andrew Harrison, says: "This is the first study to demonstrate a link between laboratory worker solvent exposure and symptoms of autoimmune connective tissue disease and has important implications for workplace health and safety."

Dr Harrison recently presented this study at the Australian Rheumatology Association Scientific Meeting in Brisbane.

 
More articles :

» Cell Therapy Yields Promising Results For Scleroderma Treatment

Cytori Therapeutics, Inc. provided preliminary data from a study evaluating a potential treatment for Scleroderma based on the company's cell therapy. The investigator-funded, open-label, pilot study is being conducted on patients with Cutaneous...

» Anticoagulation of Systemic Sclerosis Patients In Question

Australia is in a state of ‘clinical equipoise’ over whether to anticoagulate systemic sclerosis patients with pulmonary hypertension, experts say. And with observational studies showing the treatment is associated with a  fivefold...

» Long Term Methotrexate Therapy Beneficial for Juvenile Localized Scleroderma

Researchers in Italy evaluated 65 patients with Juvenile Localized (JLS; or) previously enrolled in a double blind, randomized control trial and treated for the first 3 months with oral methotrexate (MTX; 15 mg/m2 weekly) and prednisone (1 mg/kg...

» New Formulation of PAH Medication Is Now Available

Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, is now commercially available, according to the drug's maker, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif.The product is...

» Scleroderma Foundation's 13th Annual National Patient Education Conference Is Here

Nearly 600 people are anticipated to visit the heart of San Francisco Friday, July 8, through Sunday, July 10, for the Scleroderma Foundation's 13th Annual National Patient Education Conference. Patients, family members, caregivers, doctors and...

» Oral Health of Chinese People with Systemic Sclerosis

Clive M. K. Yeung; Ian A. Lai; C. H. Chu; W. Keung Leung; Mo Yin MokThe University of Hong KongReceived: 22 July 2010 / Accepted: 28 September 2010 / Published online: 12 October 2010Scleroderma is a symptom of a group of diseases that involve the...

Comments  

 
+1 #1 adelwyn 2011-07-02 12:49
This is such a shame. Saw a couple comments on your facebook page where many people confirmed this, from their own personal experiences working in health care.
Report to administrator